canakinumab
novartis
['canopy-a']
 main difference among cantos and canopy-a trial (besides the indication) is the fact that no systemic inflammation was required for eligibility in canopy-a (measured by hscrp).
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm